Evaluation of Antidepressant-Like Activity of Novel Water-Soluble Curcumin Formulations and St. John's Wort in Behavioral Paradigms of Despair

被引:24
作者
Kulkarni, S. K. [1 ]
Akula, Kiran Kumar [1 ]
Deshpande, Jayant [2 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Div Pharmacol, Chandigarh 160014, India
[2] OmniAct Hlth Technol Ltd, Thana, India
关键词
Curcumin; St. John's wort; Forced swimming test; Serotonin; Dopamine; Norepinephrine; MICE; REVERSAL;
D O I
10.1159/000335660
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Curcumin is the active principle of Curcuma Ionga, one of the widely used components in the traditional system of medicine in India. Despite its efficacy in experimental studies aiming at neuronal disorders like depression, curcumin's poor water solubility challenges the production of therapeutic formulations. This study investigates the antidepressant-like activity of novel water-soluble curcumin formulations, dispensed in three different concentrations. Further, the study comparatively evaluates St. John's wort (SJW), another herbal preparation. Methods: These compounds were evaluated in the forced swimming test in mice, and the corresponding changes in the neurotransmitter levels were measured. Results: Three water-soluble curcumin formulations, C-5, C-20 and C-50 (50-200 mg/kg p.o.) decreased the immobility period, and increased serotonin and dopamine levels in the brain tissues. A subeffective dose (50 mg/kg) of these formulations enhanced the antidepressant-like effect of classical antidepressants with varied mechanisms of action. In addition, an SJW dose of 25 mg/kg showed a significant antidepressant-like effect in all the behavioral studies and also significantly increased brain neurotransmitter levels, especially that of serotonin. The effects produced by C-5 were comparable with those of SJW and fluoxetine, respectively. Conclusion:In all these observations, the water-soluble formulations showed a significant antidepressant-like effect, including enhancement of neurotransmitter levels as compared to the similar dose of a conventional curcumin preparation. Thus, these formulations may be used as a novel treatment option in the management of mental depression. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:83 / 90
页数:8
相关论文
共 24 条
[1]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[2]  
[Anonymous], 1996, J Cell Biochem Suppl, V26, P72
[3]   Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease [J].
Baum, Larry ;
Lam, Christopher Wai Kei ;
Cheung, Stanley Kwok-Kuen ;
Kwok, Timothy ;
Lui, Victor ;
Tsoh, Joshua ;
Lam, Linda ;
Leung, Vivian ;
Hui, Elsie ;
Ng, Chelsia ;
Woo, Jean ;
Chiu, Helen Fung Kum ;
Goggins, William B. ;
Zee, Benny Chung-Ying ;
Cheng, King Fai ;
Fong, Carmen Yuet Shim ;
Wong, Adrian ;
Mok, Hazel ;
Chow, Moses Sing Sum ;
Ho, Ping Chuen ;
Ip, Siu Po ;
Ho, Chung Shun ;
Yu, Xiong Wen ;
Lai, Caroline Yau Lin ;
Chan, Ming-Houng ;
Szeto, Samuel ;
Chan, Iris Hiu Shuen ;
Mok, Vincent .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) :110-113
[4]  
Butterweck V, 2007, WIEN MED WOCHENSCHR, V157, P356, DOI 10.1007/s10354-007-0440-8
[5]  
Carpenter DJ, 2011, ALTERN MED REV, V16, P17
[6]  
Chen XW., 2011, Curr Med Chem
[7]   New Therapeutic Strategy for Mood Disorders [J].
Crupi, R. ;
Marino, A. ;
Cuzzocrea, S. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (28) :4284-4298
[8]   Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes [J].
Dhir, A ;
Naidu, PS ;
Kulkarni, SK .
ADDICTION BIOLOGY, 2005, 10 (04) :329-335
[9]  
Greden JF, 2002, J CLIN PSYCHIAT, V63, P3
[10]  
Greden John F., 2001, Journal of Clinical Psychiatry, V62, P26